世界のエピネフリン自己注射器市場は、予測期間中に約9.68 %のCAGRで成長し、2023年から2027年の間に20億1,433万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、アレルギーの有病率の増加、マーケティング戦略、アナフィラキシーに対する意識の高まり、革新的なエピネフリン自己注射器の入手可能性などによって牽引されています。
本調査では、今後数年間のエピネフリン自己注射器市場の成長を促進する主要な理由の1つとして、暫定的な製品の発売を挙げています。また、エピネフリン自己注射器と患者支援プログラムに関する意識の高まりは、市場での大きな需要につながると思われます。
TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なエピネフリン自己注射器市場ベンダーの詳細な分析を提供します
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Dosage
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global epinephrine autoinjector market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global epinephrine autoinjector market 2017 - 2021 ($ million)
4.2 Dosage Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Dosage Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Dosage
6.1 Market segments
Exhibit 30: Chart on Dosage - Market share 2022-2027 (%)
Exhibit 31: Data Table on Dosage - Market share 2022-2027 (%)
6.2 Comparison by Dosage
Exhibit 32: Chart on Comparison by Dosage
Exhibit 33: Data Table on Comparison by Dosage
6.3 0.30gm - Market size and forecast 2022-2027
Exhibit 34: Chart on 0.30gm - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on 0.30gm - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on 0.30gm - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on 0.30gm - Year-over-year growth 2022-2027 (%)
6.4 0.15gm - Market size and forecast 2022-2027
Exhibit 38: Chart on 0.15gm - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on 0.15gm - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on 0.15gm - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on 0.15gm - Year-over-year growth 2022-2027 (%)
6.5 0.50gm - Market size and forecast 2022-2027
Exhibit 42: Chart on 0.50gm - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on 0.50gm - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on 0.50gm - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on 0.50gm - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Dosage
Exhibit 46: Market opportunity by Dosage ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 47: Chart on End-user - Market share 2022-2027 (%)
Exhibit 48: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 49: Chart on Comparison by End-user
Exhibit 50: Data Table on Comparison by End-user
7.3 Hospitals and clinics - Market size and forecast 2022-2027
Exhibit 51: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
7.4 Homecare - Market size and forecast 2022-2027
Exhibit 55: Chart on Homecare - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Homecare - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Homecare - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Homecare - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by End-user
Exhibit 59: Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 101: Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 Adamis Pharmaceuticals Corp.
Exhibit 108: Adamis Pharmaceuticals Corp. - Overview
Exhibit 109: Adamis Pharmaceuticals Corp. - Business segments
Exhibit 110: Adamis Pharmaceuticals Corp. - Key offerings
Exhibit 111: Adamis Pharmaceuticals Corp. - Segment focus
12.4 ALK Abello AS
Exhibit 112: ALK Abello AS - Overview
Exhibit 113: ALK Abello AS - Product / Service
Exhibit 114: ALK Abello AS - Key offerings
12.5 Amneal Pharmaceuticals Inc.
Exhibit 115: Amneal Pharmaceuticals Inc. - Overview
Exhibit 116: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 117: Amneal Pharmaceuticals Inc. - Key news
Exhibit 118: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 119: Amneal Pharmaceuticals Inc. - Segment focus
12.6 Bausch Health Co Inc.
Exhibit 120: Bausch Health Co Inc. - Overview
Exhibit 121: Bausch Health Co Inc. - Business segments
Exhibit 122: Bausch Health Co Inc. - Key news
Exhibit 123: Bausch Health Co Inc. - Key offerings
Exhibit 124: Bausch Health Co Inc. - Segment focus
12.7 BIOPROJET
Exhibit 125: BIOPROJET - Overview
Exhibit 126: BIOPROJET - Product / Service
Exhibit 127: BIOPROJET - Key offerings
12.8 Crossject
Exhibit 128: Crossject - Overview
Exhibit 129: Crossject - Product / Service
Exhibit 130: Crossject - Key offerings
12.9 Halozyme Therapeutics Inc.
Exhibit 131: Halozyme Therapeutics Inc. - Overview
Exhibit 132: Halozyme Therapeutics Inc. - Product / Service
Exhibit 133: Halozyme Therapeutics Inc. - Key offerings
12.10 kaleo Inc.
Exhibit 134: kaleo Inc. - Overview
Exhibit 135: kaleo Inc. - Product / Service
Exhibit 136: kaleo Inc. - Key offerings
12.11 Shionogi and Co. Ltd.
Exhibit 137: Shionogi and Co. Ltd. - Overview
Exhibit 138: Shionogi and Co. Ltd. - Product / Service
Exhibit 139: Shionogi and Co. Ltd. - Key offerings
12.12 Teva Pharmaceutical Industries Ltd.
Exhibit 140: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 141: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 142: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 143: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 144: Teva Pharmaceutical Industries Ltd. - Segment focus
12.13 Viatris Inc.
Exhibit 145: Viatris Inc. - Overview
Exhibit 146: Viatris Inc. - Business segments
Exhibit 147: Viatris Inc. - Key offerings
Exhibit 148: Viatris Inc. - Segment focus
12.14 Windgap Medical Inc.
Exhibit 149: Windgap Medical Inc. - Overview
Exhibit 150: Windgap Medical Inc. - Product / Service
Exhibit 151: Windgap Medical Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 152: Inclusions checklist
Exhibit 153: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 154: Currency conversion rates for US$
13.4 Research methodology
Exhibit 155: Research methodology
Exhibit 156: Validation techniques employed for market sizing
Exhibit 157: Information sources
13.5 List of abbreviations
Exhibit 158: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Dosage
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global epinephrine autoinjector market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Dosage Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Dosage - Market share 2022-2027 (%)
Exhibits31: Data Table on Dosage - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Dosage
Exhibits33: Data Table on Comparison by Dosage
Exhibits34: Chart on 0.30gm - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on 0.30gm - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on 0.30gm - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on 0.30gm - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on 0.15gm - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on 0.15gm - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on 0.15gm - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on 0.15gm - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on 0.50gm - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on 0.50gm - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on 0.50gm - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on 0.50gm - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Dosage ($ million)
Exhibits47: Chart on End-user - Market share 2022-2027 (%)
Exhibits48: Data Table on End-user - Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by End-user
Exhibits50: Data Table on Comparison by End-user
Exhibits51: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Homecare - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Homecare - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Homecare - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Homecare - Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by End-user ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Adamis Pharmaceuticals Corp. - Overview
Exhibits109: Adamis Pharmaceuticals Corp. - Business segments
Exhibits110: Adamis Pharmaceuticals Corp. - Key offerings
Exhibits111: Adamis Pharmaceuticals Corp. - Segment focus
Exhibits112: ALK Abello AS - Overview
Exhibits113: ALK Abello AS - Product / Service
Exhibits114: ALK Abello AS - Key offerings
Exhibits115: Amneal Pharmaceuticals Inc. - Overview
Exhibits116: Amneal Pharmaceuticals Inc. - Business segments
Exhibits117: Amneal Pharmaceuticals Inc. - Key news
Exhibits118: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits119: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits120: Bausch Health Co Inc. - Overview
Exhibits121: Bausch Health Co Inc. - Business segments
Exhibits122: Bausch Health Co Inc. - Key news
Exhibits123: Bausch Health Co Inc. - Key offerings
Exhibits124: Bausch Health Co Inc. - Segment focus
Exhibits125: BIOPROJET - Overview
Exhibits126: BIOPROJET - Product / Service
Exhibits127: BIOPROJET - Key offerings
Exhibits128: Crossject - Overview
Exhibits129: Crossject - Product / Service
Exhibits130: Crossject - Key offerings
Exhibits131: Halozyme Therapeutics Inc. - Overview
Exhibits132: Halozyme Therapeutics Inc. - Product / Service
Exhibits133: Halozyme Therapeutics Inc. - Key offerings
Exhibits134: kaleo Inc. - Overview
Exhibits135: kaleo Inc. - Product / Service
Exhibits136: kaleo Inc. - Key offerings
Exhibits137: Shionogi and Co. Ltd. - Overview
Exhibits138: Shionogi and Co. Ltd. - Product / Service
Exhibits139: Shionogi and Co. Ltd. - Key offerings
Exhibits140: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits141: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits142: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits143: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits144: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits145: Viatris Inc. - Overview
Exhibits146: Viatris Inc. - Business segments
Exhibits147: Viatris Inc. - Key offerings
Exhibits148: Viatris Inc. - Segment focus
Exhibits149: Windgap Medical Inc. - Overview
Exhibits150: Windgap Medical Inc. - Product / Service
Exhibits151: Windgap Medical Inc. - Key offerings
Exhibits152: Inclusions checklist
Exhibits153: Exclusions checklist
Exhibits154: Currency conversion rates for US$
Exhibits155: Research methodology
Exhibits156: Validation techniques employed for market sizing
Exhibits157: Information sources
Exhibits158: List of abbreviations
